Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Austar Lifesciences Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
2
With ROE of 1.64%, it has a Expensive valuation with a 0.75 Price to Book Value
- Over the past year, while the stock has generated a return of 67.24%, its profits have risen by 133.5% ; the PEG ratio of the company is 0.3
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Industrial Manufacturing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Austar Lifesciences Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Austar Lifesciences Ltd.
70.18%
0.31
99.02%
Hang Seng Hong Kong
27.36%
1.03
25.88%
Quality key factors
Factor
Value
Sales Growth (5y)
5.50%
EBIT Growth (5y)
1.52%
EBIT to Interest (avg)
7.29
Debt to EBITDA (avg)
0.73
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
1.75
Tax Ratio
36.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.51%
ROE (avg)
9.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
46
Industry P/E
Price to Book Value
0.75
EV to EBIT
143.82
EV to EBITDA
12.82
EV to Capital Employed
0.80
EV to Sales
0.50
PEG Ratio
0.34
Dividend Yield
NA
ROCE (Latest)
0.55%
ROE (Latest)
1.64%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Austar Lifesciences Ltd.
Inventory Turnover Ratio
Highest at 4.99%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
Highest at HKD 30.26 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 30.26 MM has Grown at 10.76%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Austar Lifesciences Ltd.
Pre-Tax Profit
Fallen at -68.79%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Non Operating Income
Highest at HKD 1.95 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income






